This page will host Events plug-in for all Clarion and trade events.

Upcoming Events

View Calendar
Recent Quotes
My Watchlist
Indicators
EL&P Market Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Corcept Therapeutics Incorporated - Common Stock (NQ:CORT)

70.23 -1.15 (-1.61%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 953,403
Open 70.62
Bid (Size) 65.08 (1)
Ask (Size) 70.16 (1)
Prev. Close 71.38
Today's Range 69.74 - 71.27
52wk Range 26.53 - 117.33
Shares Outstanding 115,926,629
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Looking for growth without the hefty price tag? Consider CORCEPT THERAPEUTICS INC (NASDAQ:CORT).
Uncover the potential of CORCEPT THERAPEUTICS INC, a growth stock reasonably priced. NASDAQ:CORT is excelling in growth aspects, maintaining a healthy financial position, and still offers an attractive... 
Via Chartmill
How Do Investors Really Feel About Corcept Therapeutics?
Via Benzinga

Performance

YTD
+40.5%
+40.5%
1 Month
+3.7%
+3.7%
3 Month
+4.0%
+4.0%
6 Month
+18.9%
+18.9%
1 Year
+159.7%
+159.7%

More News

Read More
Will CORCEPT THERAPEUTICS INC (NASDAQ:CORT) breakout?
Via Chartmill
1 Small-Cap Stock Worth Your Attention and 2 to Question
Via StockStory
Assessing Corcept Therapeutics: Insights From 9 Financial Analysts
Via Benzinga
Earnings Scheduled For May 5, 2025
Via Benzinga
Corcept Therapeutics Stock Jumps On Record Prescription Volume: Retail Sentiment Soars
Via Stocktwits
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Corcept (NASDAQ:CORT) Misses Q1 Sales Targets, Stock Drops
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Top movers in Monday's after hours session
Via Chartmill
CORCEPT THERAPEUTICS ANNOUNCES FIRST QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
From Corcept Therapeutics
Via Business Wire
Corcept (CORT) To Report Earnings Tomorrow: Here Is What To Expect
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
CORCEPT THERAPEUTICS INC (NASDAQ:CORT), a strong growth stock, setting up for a breakout.
Via Chartmill
CORCEPT THERAPEUTICS TO ANNOUNCE FIRST QUARTER FINANCIAL RESULTS, PROVIDE CORPORATE UPDATE AND HOST CONFERENCE CALL
From Corcept Therapeutics Incorporated
Via Business Wire
3 Healthcare Stocks That Concern Us
Via StockStory
Topics Stocks
Exposures COVID-19 US Equities
Here's How Much $1000 Invested In Corcept Therapeutics 10 Years Ago Would Be Worth Today
Via Benzinga
CORCEPT TO PRESENT LATE-BREAKING DATA FROM PIVOTAL PHASE 3 ROSELLA TRIAL OF RELACORILANT IN PLATINUM-RESISTANT OVARIAN CANCER AT ASCO 2025
From Corcept Therapeutics Incorporated
Via Business Wire
Diabetes Care Publishes Results From Prevalence Phase Of Corcept’s CATALYST Trial In People With Difficult-To-Control Type 2 Diabetes
From Corcept Therapeutics Incorporated
Via Business Wire
SoundHound AI, Domo, Plug Power, Corcept, and 8x8 Shares Are Falling, What You Need To Know
Via StockStory
Topics Artificial Intelligence Economy Government
Exposures Artificial Intelligence Economy Interest Rates
$1000 Invested In Corcept Therapeutics 20 Years Ago Would Be Worth This Much Today
Via Benzinga
Investors seeking growth at a reasonable cost should explore CORCEPT THERAPEUTICS INC (NASDAQ:CORT).
Via Chartmill
3 Biopharmaceutical Stocks Bucking the Sell-Off
Via MarketBeat
Topics World Trade
Exposures Product Safety Tariff
Q4 Earnings Highs And Lows: Eli Lilly (NYSE:LLY) Vs The Rest Of The Branded Pharmaceuticals Stocks
Via StockStory
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property
Q4 Earnings Roundup: Organon (NYSE:OGN) And The Rest Of The Branded Pharmaceuticals Segment
Via StockStory
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property
Corcept Initiates Trial of Relacorilant Plus Nab-Paclitaxel and Bevacizumab in Patients With Platinum-Resistant Ovarian Cancer
From Corcept Therapeutics Incorporated
Via Business Wire

Frequently Asked Questions

Is Corcept Therapeutics Incorporated - Common Stock publicly traded?
Yes, Corcept Therapeutics Incorporated - Common Stock is publicly traded.
What exchange does Corcept Therapeutics Incorporated - Common Stock trade on?
Corcept Therapeutics Incorporated - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Corcept Therapeutics Incorporated - Common Stock?
The ticker symbol for Corcept Therapeutics Incorporated - Common Stock is CORT on the Nasdaq Stock Market
What is the current price of Corcept Therapeutics Incorporated - Common Stock?
The current price of Corcept Therapeutics Incorporated - Common Stock is 70.23
When was Corcept Therapeutics Incorporated - Common Stock last traded?
The last trade of Corcept Therapeutics Incorporated - Common Stock was at 05/09/25 04:00 PM ET
What is the market capitalization of Corcept Therapeutics Incorporated - Common Stock?
The market capitalization of Corcept Therapeutics Incorporated - Common Stock is 8.14B
How many shares of Corcept Therapeutics Incorporated - Common Stock are outstanding?
Corcept Therapeutics Incorporated - Common Stock has 8B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.